Search by Drug Name or NDC
NDC 75834-0280-30 POTASSIUM IODIDE 1 g/mL Details
POTASSIUM IODIDE 1 g/mL
POTASSIUM IODIDE is a ORAL SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Nivagen Pharmaceuticals, Inc.. The primary component is POTASSIUM IODIDE.
MedlinePlus Drug Summary
Potassium iodide is used to protect the thyroid gland from taking in radioactive iodine that may be released during a nuclear radiation emergency. Radioactive iodine can damage the thyroid gland. You should only take potassium iodide if there is a nuclear radiation emergency and public officials tell you that you should take it. Potassium iodide is in a class of medications called anti-thyroid medications. It works by blocking radioactive iodine from entering the thyroid gland. Potassium iodide can protect you from the effects of radioactive iodine that may be released during a nuclear radiation emergency, but will not protect you from other dangerous substances that may be released during the emergency. Public officials may tell you to do other things to protect yourself during the emergency. Follow all of these directions carefully.
Related Packages: 75834-0280-30Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Potassium Iodide
Product Information
| NDC | 75834-0280 |
|---|---|
| Product ID | 75834-280_62e50e38-f41a-4dc9-96e8-37a7c677bec5 |
| Associated GPIs | 43202010002060 |
| GCN Sequence Number | 001676 |
| GCN Sequence Number Description | potassium iodide SOLUTION 1 G/ML ORAL |
| HIC3 | C3H |
| HIC3 Description | IODINE CONTAINING AGENTS |
| GCN | 05011 |
| HICL Sequence Number | 000748 |
| HICL Sequence Number Description | POTASSIUM IODIDE |
| Brand/Generic | Generic |
| Proprietary Name | POTASSIUM IODIDE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | POTASSIUM IODIDE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SOLUTION |
| Route | ORAL |
| Active Ingredient Strength | 1 |
| Active Ingredient Units | g/mL |
| Substance Name | POTASSIUM IODIDE |
| Labeler Name | Nivagen Pharmaceuticals, Inc. |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | UNAPPROVED DRUG OTHER |
| Application Number | n/a |
| Listing Certified Through | 2024-12-31 |
Package
NDC 75834-0280-30 (75834028030)
| NDC Package Code | 75834-280-30 |
|---|---|
| Billing NDC | 75834028030 |
| Package | 30 mL in 1 BOTTLE, WITH APPLICATOR (75834-280-30) |
| Marketing Start Date | 2021-12-29 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |